Intravenous Iron — International


Project Line:
Health Technology Review
Project Number:

The World Health Organization guidelines define anemia as a circulating hemoglobin concentration of less than 13 g/dL for men and less than 12 g/dL for non-pregnant women. More than 50% of anemia cases are caused by iron deficiency. Iron deficiency can occur in two forms: absolute iron deficiency (iron deficiency anemia) or functional iron deficiency (anemia of inflammation). Oral iron is the treatment of choice for iron deficiency anemia. Those who are unresponsive or intolerant to oral iron are candidates for intravenous iron. While oral iron is inexpensive and easy to administer, parenteral iron is costly and requires ancillary services for administration.

The purpose of the scan is to provide an overview of the drug utilization criteria for prescribing parenteral iron preparations in countries with a universal pharmacare program.


International Policies on Parenteral Iron: An Environmental Scan

Environmental Scan
PUBLISHED: October 2019